Company Profile

ALTERITY THERAPEUTICS (NASDAQ: ATHE)
12:48 PM EDT, 05/29/20
Last: $0.57 Change: -0.03 %Change: -5.47% Volume: 67,311
Detailed Quote
Open: $ 0.58   Volume: 67,311
High: $ 0.61   Yield(%) n/a
Low: $ 0.57   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 10.43M
EPS ($) n/a   Shares Out: 1.04B
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -14.95
% Price Change (last 13 weeks): -1.21
% Price Change (last 26 weeks): -38.13
% Price Change (last 52 weeks): -55.01
% Price Change (year to date): -23.38
Management Effectiveness
Return on Equity (%): -75.10
Return on Assets (%): -63.46
Return on Invested Capital (%): -36.22
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $0.62
200-day Moving Average: $0.85
Avg. Daily Vol. (last 50 days): 453,165
Avg. Daily Vol. (last 200 days): 139,235
52-wk high: $1.50
52-wk low: $0.28
Bid: $0.57
Ask: $0.58
Company Information
Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
ALTERITY THERAPEUTICS
460 Bourke Street Level 3
Melbourne VI 3000

Phone: 61.3.9349.4906
Fax: 61.3.9348.0377
http://www.pranabio.com
Per Share Data
Earnings (1year) ($): -0.45
Annual Dividend ($): n/a
Current P/E Ratio (ttm): n/a
Book Value ($): 0.81
Cash Flow ($): -0.61
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 1.62
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 5.98
Current Ratio (x): 5.98
LT Debt/Equity (x): 0.00
Total Debt/Equity (x): 0.00



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.